Shida, T., Kamei, N. and Takeda-Morishita, M. (2013) Colonic Delivery of Docosahexaenoic Acid Improves Impaired Glucose Tolerance via GLP-1 Secretion and Suppresses Pancreatic Islet Hyperplasia in Diabetic KK-Ay Mice. International Journal of Pharmacology, 450, 63-69.
http://dx.doi.org/10.1016/j.ijpharm.2013.04.029

has been cited by the following article:

• TITLE: Antidiabetic Effects of Omega-3 Polyunsaturated Fatty Acids: From Mechanism to Therapeutic Possibilities

  AUTHORS: Yuko Iwase, Noriyasu Kamei, Mariko Takeda-Morishita

  KEYWORDS: Omega-3 Polyunsaturated Fatty Acids, Diabetes, Insulin Secretion, Docosahexaenoic Acid

  JOURNAL NAME: Pharmacology & Pharmacy, Vol.6 No.3, March 24, 2015

  ABSTRACT: Diabetes mellitus (DM) is chronic disease characterized by hyperglycemia and insulin resistance caused by dysfunction of pancreatic β cells. Over the past few decades, epidemiological studies have suggested that dietary long-chain polyunsaturated fatty acids such as docosahexaenoic acid and eicosapentaenoic acid decrease the risk of metabolic diseases including DM. The mechanisms underlying the therapeutic efficacy of dietary long-chain polyunsaturated fatty acids in treating DM have been partly revealed. In this review, the authors describe the antidiabetic effects of long-chain polyunsaturated fatty acids and also discuss their possibilities as therapeutics for DM in the light of recent findings.